Products for Research Use Only
RegisterLogin

ZK824190

CAT: 0804-HY-126361Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-126361Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ZK824190 is an orally available and selective urokinase plasminogen activator (uPA) inhibitor as a potential treatment for multiple sclerosis. IC50s of 237, 1600 and 1850 nM for uPA, tPA, and Plasmin, respectively[1].
CAS Number
2254001-81-3
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
PAI-1; Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zk824190.html
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CC[C@@H](OC1=NC(OC2=CC(C3=CC=CC(CN)=C3)=CC=C2)=C(F)C=C1F)C(O)=O
Molecular Formula
C22H20F2N2O4
Molecular Weight
414.40
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Islam I, et al. Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorg Med Chem Lett. 2018 Nov 1;28 (20) :3372-3375.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Alternative Products

CatalogName
MBS3615148-01ZK824190
A22591-25ZK824190 25mg
A22591-5ZK824190 5mg
GTR19185856-01ZK824190 hydrochloride
A22591-100ZK824190 100mg
A22591-50ZK824190 50mg
A22591-10ZK824190 10mg
A22591-1ZK824190 1mg
A22591-10mM-DZK824190 10mM * 1mL in DMSO

Popular Products